In Situ Hybridization Market Anticipated to Experience Robust Growth Due to Rising Demand for Molecular Diagnostic Techniques and Advancements in Cancer Research

The in situ hybridization market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to early adoption in research, evolution of molecular biology tools, diagnostic applications development, shift in biomedical research focus, increasing investment in biotechnology..

The in situ hybridization market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing adoption in clinical diagnostics, growth in research and development funding, automation and high-throughput solutions, expanded applications in neuroscience and pathology.. Major trends in the forecast period include advancements in molecular biology, rising demand in research applications, diagnostic applications expansion, demand for personalized medicine, increased funding in biomedical research..

Market Overview -
In-situ hybridization refers to the method that enables the exact localization of a certain nucleic acid segment inside a histologic slice. In-situ hybridization is used for identifying sequences of nucleotides in tissues, including complete tissues, portions of tissues, and cells.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

The Surging Role Of In-Situ Hybridization In Tackling Infectious Diseases
Increasing infectious diseases are expected to propel the growth of the in-situ hybridization market going forward. Infectious diseases refer to conditions that transmit from one individual to another via polluted foods and beverages and through pathogens such as viruses, bacteria, fungi, and parasites. By utilizing labeled nucleic acid sequences (probes) particular to the infectious organism, in situ hybridization (ISH) seeks to identify complementary nucleic acid sequences that are present in the tissue, so an increasing infectious disease boosts the growth of the in-situ hybridization market. For instance, in December 2022, according to the Annual Epidemiological Report for 2021 published by the European Centre for Disease Prevention and Control, a Sweden-based European government health agency, the distribution of hepatitis C cases and rates per 100,000 population in Germany reached 4,718 cases and 5.7 rates, respectively, from 4,536 cases and 5.5 rates. Therefore, increasing infectious diseases are driving the growth of the in-situ hybridization market.

Competitive Landscape -
Major companies operating in the in situ hybridization market report are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, AdvanDx Inc., Affymetrix Inc., Akoya Biosciences Inc., Becton Dickinson and Company (BD), Cell Signaling Technology Inc., DAKO Systemtechnik und Service GmbH & Co, Life Technologies, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

Technological Trends Steering The In-Situ Hybridization Market
Technological developments are the key trend gaining popularity in the -situ hybridization market. Major companies operating in the in-situ hybridization market are focusing on the development of technologies to sustain their position in the market. For instance, in April 2021, Bio-Techne Corporation, a US-based biotech company engaged in the manufacturing and commercialization of science reagents, and instruments, launched RNAscope technology and marketed a new DNAscope Assays. The RNAscope technology is an enhanced in situ hybridization (ISH) technique that allows direct visualization of single-molecule transcription with single-cell resolution in unaltered cells and tissues. Since DNAscope uses the tried-and-true 'double-Z' probe design and signal enhancement system of RNAscope, it can swiftly and easily create probes for any DNA target and allow for target visualization in formalin-fixed paraffin-embedded (FFPE) tissues.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Key Segments -

The in situ hybridization market covered in this report is segmented -

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products
2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)
3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications
5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.